Synovial surfactant: lamellar bodies in type B synoviocytes and proteolipid in synovial fluid and the articular lining.
Previous studies have shown that synovial surfactant could have beneficial roles in the joint, especially as a very effective boundary lubricant capable of high load bearing. This study is aimed at further characterization and identification of the source. Known to be an important minor component of pulmonary surfactant, proteolipid has now been detected in appreciable quantities in bovine synovial fluid and bound to the articular surface. Using standard procedures to separate it from the major component [surface-active phospholipid (SAPL)] by column chromatography, proteolipid: phospholipid ratios were found to be comparable to those in the lung or in lamellar bodies (LBs). LBs are the unequivocal source of surfactant in the lung and we have confirmed an earlier study demonstrating their presence in Type B synoviocytes. Using a fixation procedure specifically designed to preserve the graphite-like structure of SAPL deposited as oligolamellar layers, or coiled as lamellar bodies, we were able to demonstrate these structures in equine joints adjacent to the Golgi apparatus associated with the secretory mechanism of the cell. These results indicate that proteolipid could be facilitating the deposition of the graphite-like surface lining of SAPL providing efficient boundary lubrication just as it promotes surfactant adsorption in the lung and in the formation of myelin. Any deficiency in synovial surfactant, compromising its roles in the joint, is discussed in relation to osteoarthritis and the possible administration of exogenous SAPL to the degenerating joint.